who is a candidate for glp-1 Are You Good Weight Loss Treatment? When to Start GLP-1 Therapy

Showing the newest creator mentions for this item

Chem Soc Rev 40:387426

Zu Beginn und am Ende der Studie wurde fr jeden Teilnehmer ein umfassendes Blutbild angefertigt, das keine negativen Auswirkungen zeigte

These findings demonstrated that the use of pemvidutide may have important effects on the quality of weight loss and cardiometabolic-associated comorbidities of obesity

Future studies with larger sample sizes will be needed to validate these findings and to enable more detailed modeling of potential period and carry-over effects

But within 12 months of stopping treatment, they regained two-thirds of the weight they had lost, along with a significant reversal of improvements in some cardiometabolic markers, such as those related to diabetes and heart disease